End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
160.8 MXN | -.--% |
|
-.--% | -.--% |
Jun. 27 | Hansa Biopharma AB Announces Board Appointments | CI |
May. 31 | Hansa Biopharma Finalizes Patient Randomization for Use of Imlifidase inKidney Transplantation Trial | MT |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
331M | - | |||||
47.07B | - | |||||
42.06B | ||||||
39.98B | ||||||
33.02B | - | |||||
27.9B |